Registries supporting new drug applications
نویسندگان
چکیده
منابع مشابه
Registries supporting new drug applications
PURPOSE Knowledge of the benefits and risks of new drugs is incomplete at the time of marketing approval. Registries offer the possibility for additional, post-approval, data collection. For all new drugs, which were approved in the European Union between 2007 and 2010, we reviewed the frequency, the type, and the reason for requiring a registry. METHODS The European Public Assessment Reports...
متن کاملPublication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis
BACKGROUND The United States (US) Food and Drug Administration (FDA) approves new drugs based on sponsor-submitted clinical trials. The publication status of these trials in the medical literature and factors associated with publication have not been evaluated. We sought to determine the proportion of trials submitted to the FDA in support of newly approved drugs that are published in biomedica...
متن کاملClinical registries: governance, management, analysis and applications.
Clinical registries will have an increasingly important role to play in health-care, with a number already established in cardiac surgery. This review covers the fundamentals of establishing and managing clinical registries, including legal and ethical frameworks along with intellectual property attribution. Also discussed are important issues relating to the processing of data, data extraction...
متن کاملPart 514—new Animal Drug Applications
Sec. 514.1 Applications. 514.4 Substantial evidence. 514.6 Amended applications. 514.7 Withdrawal of applications without prejudice. 514.8 Supplemental new animal drug applications. 514.11 Confidentiality of data and information in a new animal drug application file. 514.12 Confidentiality of data and information in an investigational new animal drug notice. 514.15 Untrue statements in applicat...
متن کاملA new distributed routing algorithm for supporting delay-sensitive applications
We propose a new distributed delay-constrained unicast routing algorithm which can always nd a delay-constrained path with small message complexity if such a path exists. At each network node, limited information about the network state is needed and only a small amount of computation is required. Simulation results show that the proposed algorithm has much better cost performance than the leas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmacoepidemiology and Drug Safety
سال: 2017
ISSN: 1053-8569
DOI: 10.1002/pds.4332